- Report
- February 2024
- 114 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- April 2023
- 105 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- January 2022
- 120 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- December 2023
- 140 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- July 2021
- 112 Pages
Global
From €4225EUR$4,450USD£3,563GBP
- Report
- October 2023
- 145 Pages
Global
From €2990EUR$3,150USD£2,522GBP
- Report
- May 2023
- 120 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- April 2023
- 147 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4652EUR$4,900USD£3,924GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4652EUR$4,900USD£3,924GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4652EUR$4,900USD£3,924GBP
- Report
- August 2023
- 300 Pages
Europe
From €4652EUR$4,900USD£3,924GBP
- Report
- August 2023
- 1300 Pages
Global
From €8449EUR$8,900USD£7,127GBP
- Report
- August 2023
- 51 Pages
South Korea
From €570EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Mexico
From €570EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Canada
From €570EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Saudi Arabia
From €570EUR$600USD£480GBP
From €570EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Germany
From €570EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
France
From €570EUR$600USD£480GBP

The Guide RNA (gRNA) market is a subset of the genomics industry that focuses on the development and production of gRNA molecules. gRNA molecules are used in a variety of applications, including gene editing, gene regulation, and gene expression. gRNA molecules are composed of a guide sequence, which is complementary to a specific target sequence in the genome, and a scaffold sequence, which provides stability and specificity to the gRNA molecule.
The gRNA market is driven by the increasing demand for gene editing and gene regulation technologies, as well as the growing need for more efficient and cost-effective gene expression tools. Additionally, the development of new gRNA technologies, such as CRISPR-Cas9, has further increased the demand for gRNA molecules.
Some of the major companies in the gRNA market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, New England Biolabs, and OriGene Technologies. Show Less Read more